New, Robust and Inexpensive Technique for Protein Analysis in Tissues

A new technique to study proteins, which does not require advanced equipment, specialized labs or expensive reagents, has been developed at Uppsala University, Sweden. The technique could be further developed to be used in point of care devices, for instance for diagnostic purposes. The possibility to identify and localize proteins in tissues is essential for understanding disease mechanisms and for diagnostics. However, today very advanced instruments are often needed to study proteins and how they interact with each other. An example is the microscopy technique that was awarded last year's Nobel Prize in chemistry; super resolution fluorescence microscopy.

Such equipment is expensive to purchase and often requires special training to handle. In order to use protein detection for diagnostic purposes, e.g. in a clinic, new, less complicated methods to study proteins are needed. Such methods should be temperature insensitive and not require expensive instruments, costly reagents or specially trained staff.

In the most recent issue of the journal Nature Communications the researchers present a technique that could be used by for instance hospital staff, to detect relevant proteins. The technique is based on the binding of antibodies, either to two sites on the same protein or to two proteins that are localized very close to each other. The antibodies have been linked to DNA strands that will attach to each other if they are close enough. When this happens a chain reaction will start in which increasing numbers of DNA strands are attached. To each DNA strand a fluorescent substance has been linked, which will emit light when it is irradiated with light of a certain wavelength.

"When the chain reaction has run for a while enough fluorescent molecules have been incorporated to allow us to observe them as very bright dots in a microscope, reflecting the presence of a protein of interest. The more dots there more protein," says Ola Söderberg, who has developed the technique together with Masood Kamali-Mogaddam and their research teams.

The chain reaction does not include any enzymes, which means that it can take place at room temperature. The microscopes needed to study the bright dots are relatively simple and commonly available in hospital and research labs. Since two antibodies are bound in the first step "false" signals can be avoided, making the reaction very specific for the studied protein.

"All this implies that our technique can be used as a robust and inexpensive method to localize proteins in tissues. We hope that it soon can be used both for clinical applications and for research purposes," says Ola Söderberg.

The technique has been developed in collaboration with researchers in Uppsala, Scotland and Austria. The results have been published online in the journal Nature Communications.

Reference: Proximity Dependent Initiation of Hybridization Chain Reaction, Nature Communications, DOI: 10.1038/ncomms8294

Science for Life Laboratory (SciLifeLab) is a national centre for molecular biosciences with the focus on health and environmental research. The centre combines advanced technical know-how and state-of-the art equipment with a broad knowledge of translational medicine and molecular bioscience.

Uppsala University - quality, knowledge, and creativity since 1477 World-class research and outstanding education of global benefit to society, business, and culture. Uppsala University is one of northern Europe's highest ranked academic institutions.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...